By Associate Professor Julia Lappin

Books

Darke S; Lappin J; Farrell M, 2021, The pocket guide to drugs and health, Silverback, London

Darke S; Lappin J; Farrell M, 2019, The Clinician's Guide to Illicit Drugs and Health, Silverback Publishing, Great Britain, https://www.silverbackpublishing.org/products/the-clinicians-guide-to-illicit-drugs-and-health

Book Chapters

Lappin J; Onwumere J; Murray R, 2024, 'Understanding Psychosis and Schizophrenia', in Coping with Psychosis and Schizophrenia, Cambridge University Press, pp. 1 - 12, http://dx.doi.org/10.1017/9781911623700.003

Dazzan P; Morgan K; Lappin J; Fearon P, 2012, 'Neuroimaging and psychosis: Are brain changes in individuals with psychosis neurodevelopmental for some and progressive for others?', in Schizophrenia: The Final Frontier - A Festschrift for Robin M. Murray, pp. 147 - 154, http://dx.doi.org/10.4324/9780203808771

Laurens K; Hodgins S; Taylor EA; Murray RM, 2011, 'Is earlier intervention for schizophrenia possible? Identifying antecedents of schizophrenia in children aged 9-12 years', in David AS; Kapur S; McGuffin P (ed.), Schizophrenia: The Final Frontier - A Festschrift for Robin M. Murray, Psychology Press Ltd, Taylor & Francis Press, pp. 19 - 32

Ebmeier KP; Lappin JM, 2002, 'Electromagnetic Stimulation and Affective Disorders<footref rid="foot01">¹</footref>', in Advances in Biological Psychiatry, KARGER, pp. 167 - 177, http://dx.doi.org/10.1159/000066883

Ebmeier KP; Lappin JM, 2001, 'Electromagnetic stimulation in psychiatry', in , pp. 181 - 188, http://dx.doi.org/10.1192/apt.7.3.181

Journal articles

McGuiness A; Travethan L; Irvin K; Black Y; Apps J; Corinth K; Kennedy J; Brown VZ; Morgan C; Quartly-Scott G; Rensburg PV; Rusten K; Gott C; Lappin J; Sugden N; Allan J; Dark F; Gray H; Thomas G; Hollow A; Thomas M, 2025, 'The potential of cognitive remediation therapy for improving the communication capabilities of adults with schizophrenia and other psychotic spectrum disorders', International Journal of Language and Communication Disorders, 60, http://dx.doi.org/10.1111/1460-6984.13141

Zahra E; Darke S; Lappin J; Duflou J; Farrell M, 2024, 'Baclofen-related deaths in Australia 2000–2022', Forensic Science International, 365, http://dx.doi.org/10.1016/j.forsciint.2024.112281

Rubaiya Talukder S; Lappin J; Clare Boland V; Weaver N; McRobbie H; James Courtney R, 2024, 'Mental health related adverse events of cytisine and varenicline in smokers with and without mental health disorders: Secondary analysis of a randomized controlled trial', Addictive Behaviors, 159, http://dx.doi.org/10.1016/j.addbeh.2024.108148

Darke S; Duflou J; Farrell M; Lappin J; Peacock A, 2024, 'Emergence of deaths due to nitazene toxicity in Australia', Drug and Alcohol Review, 43, pp. 2093 - 2094, http://dx.doi.org/10.1111/dar.13920

Talukder S; Lappin JM; Boland VC; Weaver N; McRobbie H; Courtney RJ, 2024, 'Receipt of the 5As intervention for smoking cessation among people with and without mental health disorders', Journal of Psychiatric Research, 179, pp. 1 - 7, http://dx.doi.org/10.1016/j.jpsychires.2024.08.023

Darke S; Duflou J; McDonald S; Peacock A; Farrell M; Lappin J, 2024, 'Neuropathology of deaths due to acute alcohol toxicity in Australia, 2011–2022', Drug and Alcohol Dependence, 263, http://dx.doi.org/10.1016/j.drugalcdep.2024.111407

Darke S; Duflou J; Peacock A; Farrell M; Hall W; Lappin J, 2024, 'A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia', Addiction, 119, pp. 1564 - 1571, http://dx.doi.org/10.1111/add.16518

Davies K; Lappin JM; Gott C; Steel Z, 2024, 'Experiencing Psychosis and Shame: A Systematic Review and Meta-analysis of the Strength and Patterns of Association.', Schizophr Bull, http://dx.doi.org/10.1093/schbul/sbae139

Lappin JM, 2024, 'Can we raise the bar?', Australian and New Zealand Journal of Psychiatry, 58, pp. 633 - 635, http://dx.doi.org/10.1177/00048674241269077

Darke S; Farrell M; Duflou J; Lappin J, 2024, 'Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications', Addiction, 119, pp. 1153 - 1155, http://dx.doi.org/10.1111/add.16407

Bolton P; Davies K; Grattan S; Lappin JM, 2024, 'Commando care for individuals living with severe mental illness: Equally Well goes beyond metabolic health alone', Australian and New Zealand Journal of Psychiatry, 58, pp. 545 - 548, http://dx.doi.org/10.1177/00048674241240601

Darke S; Duflou J; Peacock A; Chrzanowska A; Yuen WS; Farrell M; Lappin J, 2024, 'Characteristics, toxicology and major organ pathology of deaths due to acute alcohol toxicity in Australia, 2011–2022', Drug and Alcohol Review, 43, pp. 937 - 945, http://dx.doi.org/10.1111/dar.13817

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2024, 'A descriptive coronial study of heroin toxicity deaths in Australia, 2020–2022: Characteristics, toxicology and survival times', Addiction, 119, pp. 559 - 569, http://dx.doi.org/10.1111/add.16377

Weickert TW; Jacomb I; Lenroot R; Lappin J; Weinberg D; Brooks WS; Brown D; Pellen D; Kindler J; Mohan A; Wakefield D; Lloyd AR; Stanton C; O'Donnell M; Liu D; Galletly C; Shannon Weickert C, 2024, 'Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial', Brain, Behavior, and Immunity, 115, pp. 191 - 200, http://dx.doi.org/10.1016/j.bbi.2023.10.012

Darke S; Duflou J; Chrzanowska A; Farrell M; Lappin J; Peacock A, 2024, 'Changes in the rates and characteristics of gamma hydroxybutyrate (GHB)-related death in Australia, 2001–2023', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13940

Grattan S; Davies K; Weise J; Burns N; Murray R; Weldon J; Ellis R; Lappin JM, 2024, 'Development of a framework of the skills and attributes needed by mental health professionals to provide optimal clinical care to people experiencing complex psychosis: A Delphi consensus study', Australian and New Zealand Journal of Psychiatry, http://dx.doi.org/10.1177/00048674241289032

Macdonald C; Weatherburn D; Lappin J, 2024, 'Diversion into mental health treatment: a survey of magistrates and treatment plans', Psychiatry, Psychology and Law, http://dx.doi.org/10.1080/13218719.2024.2313985

Darke S; Farrell M; Lappin J, 2024, 'Rare but relevant series', Addiction, http://dx.doi.org/10.1111/add.16697

Lappin JM, 2024, 'Rare but relevant: Methamphetamine and Parkinson's disease', Addiction, http://dx.doi.org/10.1111/add.16695

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2024, 'Differences in heroin overdose deaths in Australia by age, 2020-2022: Disease and estimated survival times.', Drug Alcohol Depend Rep, 10, pp. 100217, http://dx.doi.org/10.1016/j.dadr.2024.100217

Gott CA; Thomas M; Allan J; Kennedy J; Black Y; Dark F; Lappin JM, 2023, 'Cognitive remediation therapy – implementation and translation into clinical practice in rural and metropolitan New South Wales mental health services', Australasian Psychiatry, 31, pp. 584 - 586, http://dx.doi.org/10.1177/10398562231186125

Pollard R; Fisher HL; Fearon P; Morgan K; Lappin J; Hutchinson G; Doody GA; Jones PB; Murray RM; Morgan C; Dazzan P, 2023, 'Parental bonding style and illness severity in a longitudinal study of individuals with first episode psychosis', Archives of Women's Mental Health, 26, pp. 707 - 711, http://dx.doi.org/10.1007/s00737-023-01351-y

Davies K; Grattan S; Gott C; Ellis R; Lappin JM, 2023, 'The tertiary service for psychosis: Holistic recommendations for people with complex psychosis', Australasian Psychiatry, 31, pp. 591 - 597, http://dx.doi.org/10.1177/10398562231189115

Darke S; Farrell M; Lappin J, 2023, 'Overdose and suicide are different phenomena among opioid users that require different clinical management', Australian and New Zealand Journal of Psychiatry, 57, pp. 1095 - 1100, http://dx.doi.org/10.1177/00048674231159298

Talukder SR; Lappin JM; Boland V; McRobbie H; Courtney RJ, 2023, 'Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders', Tobacco Control, 32, pp. 489 - 496, http://dx.doi.org/10.1136/tobaccocontrol-2021-056843

Srasuebkul P; Walker AR; Cvejic RC; Trollor JN; Lappin JM; Curtis J; Samaras K; Dean K; Ward PB; Reppermund S, 2023, 'Hospital service utilisation of people previously hospitalised with different subtypes of psychotic disorder: A record linkage study', Australian and New Zealand Journal of Psychiatry, 57, pp. 844 - 853, http://dx.doi.org/10.1177/00048674221115642

Lappin JM; Darke S; Farrell M, 2023, 'Psychotogenic potential of prescribed drugs', Australian and New Zealand Journal of Psychiatry, 57, pp. 777 - 779, http://dx.doi.org/10.1177/00048674231174807

Foley C; Allan J; Lappin J; Courtney R; Farnbach S; Henderson A; Shakeshaft A, 2023, 'Utilising the Implementation of Integrated Care to Develop a Pragmatic Framework for the Sustained Uptake of Service Innovations (SUSI)', Healthcare (Switzerland), 11, http://dx.doi.org/10.3390/healthcare11121786

Davies K; Courtney RJ; Summersby-Mitchell M; Morell R; Briggs N; Lappin JM, 2023, 'A systematic review of factors associated with sustained smoking abstinence in people experiencing severe mental illness following participation in a smoking intervention', Australian and New Zealand Journal of Psychiatry, 57, pp. 489 - 510, http://dx.doi.org/10.1177/00048674221147206

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2023, 'Characteristics and circumstances of cocaine-related completed suicide in Australia, 2000–2021', Drug and Alcohol Dependence, 244, http://dx.doi.org/10.1016/j.drugalcdep.2023.109803

Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2023, 'Clinical characteristics of fatal cocaine toxicity in Australia, 2000–2021', Drug and Alcohol Review, 42, pp. 582 - 591, http://dx.doi.org/10.1111/dar.13581

Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2023, 'Rates, characteristics and toxicology of cocaine-related deaths in Australia, 2000–2021', Addiction, 118, pp. 297 - 306, http://dx.doi.org/10.1111/add.16055

Cohn SL; Mohan A; Lappin JM; Curtis J; Scott JG, 2023, 'Anti-N-Methyl-D-Aspartate Receptor Antibody Testing in First-Episode Psychosis: Universal or Targeted Testing', Journal of Neuropsychiatry and Clinical Neurosciences, 35, pp. 98 - 101, http://dx.doi.org/10.1176/appi.neuropsych.21080214

Darke S; Zahra E; Duflou J; Peacock A; Farrell M; Lappin J, 2023, 'Characteristics and circumstances of volatile solvent misuse-related death in Australia, 2000–2021', Clinical Toxicology, 61, pp. 260 - 265, http://dx.doi.org/10.1080/15563650.2023.2184243

Davies K; Gott C; Ferdman A; Lloyd K; Pnevmatikos N; Chase E; Lappin J, 2023, 'Promoting psychological interventions in psychosis: the NSW Tertiary Referral Service for Psychosis', Australian Psychologist, 58, pp. 315 - 320, http://dx.doi.org/10.1080/00050067.2023.2211759

Lappin JM; Zahra E; Darke S; Shand F; Sharma S; Draper B; Connors MH; Dear B; Titov N; Campbell G, 2022, 'Presentations to the emergency department with self-harm or suicidal behaviours: A role for digital mental health services?', Journal of Psychiatric Research, 154, pp. 50 - 55, http://dx.doi.org/10.1016/j.jpsychires.2022.07.046

Lappin JM; Davies K; O'Donnell M; Walpola IC, 2022, 'Underuse of recommended treatments among people living with treatment-resistant psychosis', Frontiers in Psychiatry, 13, http://dx.doi.org/10.3389/fpsyt.2022.987468

O'Dea D; Curtis J; Scully A; Lappin J, 2022, 'A pilot study of a mindfulness informed yoga intervention in young people with psychosis', Early Intervention in Psychiatry, 16, pp. 1036 - 1042, http://dx.doi.org/10.1111/eip.13264

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal tapentadol-related toxicity in Australia', Drug and Alcohol Review, 41, pp. 1071 - 1077, http://dx.doi.org/10.1111/dar.13462

Darke S; Chrzanowska A; Campbell G; Zahra E; Lappin J, 2022, 'Barbiturate-related hospitalisations, drug treatment episodes, and deaths in Australia, 2000‒2018', Medical Journal of Australia, 216, pp. 194 - 198, http://dx.doi.org/10.5694/mja2.51306

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ synthetic opioid toxicity in Australia', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109292

Lappin J, 2022, 'Clinical Management of Withdrawal Series', Addiction, 117, pp. 517, http://dx.doi.org/10.1111/add.15708

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ benzodiazepine toxicity in Australia', Forensic Science International, 331, http://dx.doi.org/10.1016/j.forsciint.2021.111140

Back to profile page